These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3. Tomasson MH; Williams IR; Li S; Kutok J; Cain D; Gillessen S; Dranoff G; Van Etten RA; Gilliland DG Blood; 2001 Mar; 97(5):1435-41. PubMed ID: 11222391 [TBL] [Abstract][Full Text] [Related]
7. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581. Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371 [TBL] [Abstract][Full Text] [Related]
8. Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. Li G; Miskimen KL; Wang Z; Xie XY; Tse W; Gouilleux F; Moriggl R; Bunting KD Leukemia; 2010 Aug; 24(8):1397-405. PubMed ID: 20535152 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797 [TBL] [Abstract][Full Text] [Related]
10. The influence of antisense oligonucleotides against STAT5 on the regulation of normal haematopoiesis in a bone marrow model. Baśkiewicz-Masiuk M; Paczkowski M; Machaliński B Cell Prolif; 2004 Jun; 37(3):231-45. PubMed ID: 15144500 [TBL] [Abstract][Full Text] [Related]
11. A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis. Couldrey C; Bradley HL; Bunting KD Blood; 2005 Feb; 105(4):1476-83. PubMed ID: 15498858 [TBL] [Abstract][Full Text] [Related]
12. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Lacronique V; Boureux A; Valle VD; Poirel H; Quang CT; Mauchauffé M; Berthou C; Lessard M; Berger R; Ghysdael J; Bernard OA Science; 1997 Nov; 278(5341):1309-12. PubMed ID: 9360930 [TBL] [Abstract][Full Text] [Related]
13. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Frantsve J; Schwaller J; Sternberg DW; Kutok J; Gilliland DG Mol Cell Biol; 2001 May; 21(10):3547-57. PubMed ID: 11313480 [TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice. Tsuruyama T; Nakamura T; Jin G; Ozeki M; Yamada Y; Hiai H Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8253-8. PubMed ID: 12048235 [TBL] [Abstract][Full Text] [Related]
15. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. Sexl V; Piekorz R; Moriggl R; Rohrer J; Brown MP; Bunting KD; Rothammer K; Roussel MF; Ihle JN Blood; 2000 Sep; 96(6):2277-83. PubMed ID: 10979977 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplant completely rescues hematolymphoid defects in STAT5A/5B-deficient mice. Snow JW; Abraham N; Ma MC; Goldsmith MA Exp Hematol; 2003 Dec; 31(12):1247-52. PubMed ID: 14662331 [TBL] [Abstract][Full Text] [Related]